Rho-kinase activation in patients with pulmonary arterial hypertension

Circulation Journal

Volumn 73, Issue 9, 2009, Pages 1597-1598

  Watanabe, Hiroshi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; BLEOMYCIN; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; FARNESYL DIPHOSPHATE; FASUDIL; GERANYLGERANYL PYROPHOSPHATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOPRENOID; MONOCROTALINE; MYOSIN LIGHT CHAIN; NITRIC OXIDE; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE; RHO KINASE; RHO KINASE INHIBITOR; SILDENAFIL;

CLINICAL RESEARCH; DISEASE COURSE; DISEASE SEVERITY; DRUG DESIGN; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; ENZYME ACTIVITY; ENZYME INHIBITION; HEART INDEX; HEART MUSCLE RELAXATION; HUMAN; HYPOXIA; LOW DRUG DOSE; LUNG VASCULAR RESISTANCE; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN PHOSPHORYLATION; PULMONARY ARTERY; PULMONARY HYPERTENSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TREATMENT OUTCOME; VASOCONSTRICTION;

ENZYME ACTIVATION; HUMANS; HYPERTENSION, PULMONARY; LUNG; MYOSIN-LIGHT-CHAIN PHOSPHATASE; NEUTROPHILS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PULMONARY ARTERY; RHO-ASSOCIATED KINASES; SEVERITY OF ILLNESS INDEX; VASOCONSTRICTION; VASODILATION;

EID: 69549127751     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0522     Document Type: Editorial

References (15)

1. McLaughlin VV, McGoon MD. Pulmonary arterial hypertension. Circulation 2006; 114: 1417-1431.
2. Morrell NW, Adnot S, Archer SL, Dupuis J, Jones PL, MacLean MR, et al. Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54: S20-S31.
3. Barst RJ, Gibbs JSR, Ghofrani HA, Hoeper MM, McLaughlin W, Rubin LJ, et al. Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54: S78-S84.
4. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension. Circulation 2009; 119: 2250-2294.
5. Shimokawa H, Takeshita A. Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscler Thromb Vasc Biol 2005; 25: 1767-1775. (Pubitemid 41243442)
6. Guilluy C, Rolli-Derkinderen M, Tharaux PL, Melino G, Pacaud P, Loirand G. Transglutaminase-dependent RhoA activation and depletion by serotonin in vascular smooth muscle cells. J Biol Chem 2007; 282: 2918-2928. (Pubitemid 47084345)
7. Murphy KS. Signaling for contraction and relaxation in smooth muscle of the gut. Annu Rev Physiol 2006; 68: 345-374.
8. Belik J, Jankov RP, Pan J, Tanswell AK. Peroxynitrite inhibits relaxation and induces pulmonary artery muscle contraction in the newborn rat. Free Radic Biol Med 2004; 37: 1384-1392. (Pubitemid 39359158)
9. Abe K, Tawara S, Oi K, Hizume T, Uwatoku T, Fukumoto Y, et al. Long-term inhibition of Rho-kinase ameliorates hypoxia-induced pulmonary hypertension in mice. J Cardiovasc Pharmacol 2006; 48: 280-285. (Pubitemid 46066832)
10. Abe K, Shimokawa H, Morikawa K, Uwatoku T, Oi K, Matsumoto Y, et al. Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats. Circ Res 2004; 94: 385-393. (Pubitemid 38240731)
11. Hemnes AR, Zaiman A, Champion HC. PDE5A inhibition attenuates bleomycin-induced pulmonary fibrosis and pulmonary hypertension through inhibition of ROS generation and RhoA/Rho kinase activation. Am J Physiol Lung Cell Mol Physiol 2008; 294: L24-L33.
12. Rashid M, Tawara S, Fukumoto Y, Seto M, Yano K, Shimokawa H. Importance of Rac1 signaling pathway inhibition in the pleiotropic effect of HMG-CoA reductase inhibitors. Circ J 2009; 73: 361-370.
13. Ishikura K, Yamada N, Ito M, Ota S, Nakamura M, Isaka N, et al. Beneficial acute effects of Rho-kinase inhibitor in patients with pulmonary arterial hypertension. Circ J 2006; 70: 174-178. (Pubitemid 43170128)
14. Zhulanqiqige D, Fukumoto Y, Takaki A, Tawara S, Ohashi J, Nakano M, et al. Evidence for Rho-kinase activation in patients with pulmonary arterial hypertension. Circ J 2009; 73: 1731-1739.
15. Sandoval J, Bauerle O, Palomar A, Gomez A, Martinez-Guerra ML, Beltran M, et al. Survival in primary pulmonary hypertension: Validation of a prognostic equation. Circulation 1994; 89: 1733-1744. (Pubitemid 24114252)